Wedmont Private Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Wedmont Private Capital's EW Position: Q2 2026 in Review
Wedmont Private Capital reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $35.4K and leaving 13,069 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #301.
Wedmont Private Capital first reported a position in EW in Q4 2021 and has held it in 17 quarters since. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Wedmont Private Capital held 13,069 shares of Edwards Lifesciences worth $1.21M as of Q2 2026.
- Wedmont Private Capital sold 422 Edwards Lifesciences shares in Q2 2026, an estimated $35.4K.
- Edwards Lifesciences made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #301 holding.
- Wedmont Private Capital first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 17 quarters since.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.